Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK "reassured" EU will not block coronavirus vaccines

Mon, 22nd Mar 2021 16:07

(Alliance News) - UK Prime Minister Boris Johnson said Monday he was "reassured" EU leaders do not want blockades on vaccine exports, while Ireland's leader warned a threatened ban would be "very retrograde".

Britain has urged the EU not to halt exports of AstraZeneca PLC's Covid-19 vaccine in response to a shortfall in deliveries to the bloc from the Anglo-Swedish firm.

"I'm reassured by talking to EU partners over the last few months that they don't want to see blockades, I think that's very, very important," Johnson told reporters. 

"I've talked to our friends repeatedly. We're all facing the same pandemic, we all have the same problems," he added.

"Developing vaccines, rolling them out, these are international projects and they require international cooperation."

EU Chief Ursula von der Leyen on Saturday again threatened to impose an export ban on the AstraZeneca vaccine unless the company delivers more of the 90 million doses it agreed to supply in the first quarter of 2021.

Irish prime minister Micheal Martin urged Brussels not to carry out its threat.

"I'm very much against it, I think it would be a very retrograde step," he told local broadcaster RTE.

"It's absolutely vital that we keep supply chains open. (If) you start putting up barriers, other countries may follow suit in terms of some of those vital raw materials that are required.

"If we start that we are in trouble," he added, saying he had told EU leaders of his concerns last week.

The cross-Channel row is increasingly focused on a factory in the Netherlands set to produce future supplies of the AstraZeneca jab but still awaiting official approval, according to EU and UK sources.

Both Brussels and London are laying claim to the doses, they say.

EU commission spokesman Eric Mamer said Monday that the bloc was in discussions with British authorities, "and as ever the European Commission is open and constructive in trying to find solutions".

While Europe's vaccine drive has lagged – and some parts of the continent are now seeing a fresh surge in infections – Britain has vaccinated more than half of its adult population with at least one dose.

It plans to have gradually eased all lockdown restrictions by June 21 as a result.

Despite the export row and supply issues already forecast for next month, Johnson said his government would "just bash on with the roadmap that we've set out".

However, he warned the wave of new cases currently affecting continental Europe would likely hit Britain as well.

"People in this country should be under no illusions that previous experience has taught us that when a wave hits our friends it, I'm afraid, washes up on our shores as well," he said.

Britain has been one of the hardest hit countries in the pandemic, with more than 126,000 deaths.

But infections, hospitalisations and deaths have plummeted in recent weeks as the vaccination roll out takes effect.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.